A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD

NCT06981078 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

666

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Verekitug
OTHER: Placebo

Sponsor

Upstream Bio Inc.